Product NDC: | 55289-784 |
Proprietary Name: | tizanidine hydrochloride |
Non Proprietary Name: | tizanidine hydrochloride |
Active Ingredient(s): | 4 mg/1 & nbsp; tizanidine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55289-784 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076280 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020627 |
Package NDC: | 55289-784-90 |
Package Description: | 90 TABLET in 1 BOTTLE, PLASTIC (55289-784-90) |
NDC Code | 55289-784-90 |
Proprietary Name | tizanidine hydrochloride |
Package Description | 90 TABLET in 1 BOTTLE, PLASTIC (55289-784-90) |
Product NDC | 55289-784 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tizanidine hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20020627 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | TIZANIDINE HYDROCHLORIDE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |